Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

2.9K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.9K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

577
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
577
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

2.5K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.5K
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

995
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
995
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

748
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
748

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting Mitochondrial Damage as a Therapeutic for Ileal Crohn's Disease.

Cells·2021
Same author

2D correlation analysis: sequential order judging.

Analytical chemistry·2013
Same author

Clinical characteristics and outcome of isolated extramedullary relapse in acute leukemia after allogeneic stem cell transplantation: a single-center analysis.

Leukemia research·2013
Same author

Nerve injury-related autoimmunity activation leads to chronic inflammation and chronic neuropathic pain.

Anesthesiology·2013
Same author

Platelet factor-4 (CXCL4/PF-4): an angiostatic chemokine for cancer therapy.

Cancer letters·2013
Same author

[Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].

Zhonghua fu chan ke za zhi·2013
Same journal

Poststroke anticoagulation is timeless.

Proceedings (Baylor University. Medical Center)·2026
Same journal

Association of patient characteristics with preterm birth among patients with a history of preterm birth: a single-center retrospective study.

Proceedings (Baylor University. Medical Center)·2026
Same journal

Continuous glucose monitor device-associated cutaneous <i>Mycobacterium abscessus</i> infection: a novel source of primary inoculation.

Proceedings (Baylor University. Medical Center)·2026
Same journal

Unregulated gains: a case of RAD-140-induced liver injury.

Proceedings (Baylor University. Medical Center)·2026
Same journal

A likely case of guttate psoriasis precipitated by syphilis: a novel association.

Proceedings (Baylor University. Medical Center)·2026
Same journal

Evaluating the rising incidence of infant botulism and the heterogeneous distribution of cases in Texas in the wake of the November 2025 outbreak.

Proceedings (Baylor University. Medical Center)·2026
See all related articles

Related Experiment Video

Updated: Feb 27, 2026

Multimodality Diagnosis of Mesenteric Ischemia
05:07

Multimodality Diagnosis of Mesenteric Ischemia

Published on: July 21, 2023

1.3K

Olmesartan-associated enteropathy.

Vivian S Ebrahim1, Jason Martin1, Stacey Murthy1

  • 1Division of Gastroenterology, Department of Internal Medicine (Ebrahim, Martin, Odstrcil, Polter) and the Department of Pathology (Murthy, Huang), Baylor University Medical Center, Dallas, Texas.

Proceedings (Baylor University. Medical Center)
|July 4, 2017
PubMed
Summary
This summary is machine-generated.

Olmesartan medication can cause severe diarrhea and intestinal issues, known as olmesartan-associated enteropathy. This serious side effect may require hospitalization and carries significant health risks.

More Related Videos

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

1.0K
Targeting the Rat's Small Bowel: Long-Term Infusion into the Superior Mesenteric Artery
07:12

Targeting the Rat's Small Bowel: Long-Term Infusion into the Superior Mesenteric Artery

Published on: April 8, 2021

5.2K

Related Experiment Videos

Last Updated: Feb 27, 2026

Multimodality Diagnosis of Mesenteric Ischemia
05:07

Multimodality Diagnosis of Mesenteric Ischemia

Published on: July 21, 2023

1.3K
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

1.0K
Targeting the Rat's Small Bowel: Long-Term Infusion into the Superior Mesenteric Artery
07:12

Targeting the Rat's Small Bowel: Long-Term Infusion into the Superior Mesenteric Artery

Published on: April 8, 2021

5.2K

Area of Science:

  • Cardiology
  • Gastroenterology
  • Pharmacology

Background:

  • Olmesartan is a widely prescribed angiotensin-receptor blocker for hypertension.
  • Olmesartan-associated enteropathy (OAE) emerged as a significant concern in 2012.
  • The U.S. Food and Drug Administration mandates a black-box warning for olmesartan due to severe diarrhea.

Observation:

  • Presents three distinct clinical cases of olmesartan-associated enteropathy.
  • Highlights varied presentations and unusual features of the condition.
  • Emphasizes the potential severity, including life-threatening outcomes and hospitalization.

Findings:

  • Olmesartan-associated enteropathy is a serious gastrointestinal adverse effect.
  • The condition can manifest with diverse clinical and endoscopic findings.
  • Prompt recognition and drug discontinuation are crucial for patient recovery.

Implications:

  • Clinicians should maintain a high index of suspicion for OAE in patients on olmesartan presenting with diarrhea.
  • Understanding the spectrum of OAE is vital for accurate diagnosis and management.
  • Further research into the pathogenesis and long-term outcomes of OAE is warranted.